madhu2811

Marksans Pharma Ltd

Pembelian
madhu2811 Diupdate   
NSE:MARKSANS   MARKSANS PHARMA LTD
Around 51% comes from Pain Management, 11% comes from Cough & Cold, 8% comes from Cardiovascular System, 6% comes from Gastrointestinal, and the rest comes from Anti-Diabetic, AntiAllergic.

TARGET AND STOPLOSS IN CHART

Market Cap
₹ 4,176 Cr.

Current Price
₹ 92.2

High / Low
₹ 94.3 / 38.6

Stock P/E
15.8

Book Value
₹ 38.5

Dividend Yield
0.54 %

ROCE
22.5 %

ROE
18.6 %

Face Value
₹ 1.00

Promoter holding
43.8 %

EPS last year
₹ 5.88

EPS latest quarter
₹ 1.81

Debt
₹ 123 Cr.

Pledged percentage
0.00 %

Net CF
₹ 176 Cr.

Price to Cash Flow
17.6

Free Cash Flow
₹ 184 Cr.

Debt to equity
0.07

OPM last year
18.3 %

OPM 5Year
18.4 %

Reserves
₹ 1,700 Cr.

Price to book value
2.31

Int Coverage
38.0

PEG Ratio
0.31
Trade aktif
Trade aktif:
10 % up
Trade aktif:
T2 DOne
Trade aktif:
Target Done Trail SL

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.